$CERS

CERUS CORP (CERS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

CERUS CORP (CERS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001020214 0001020214 2026-07-06 2026-07-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 6, 2

Original reporting
Published Jul 10, 2026, 8:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 10, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CERS
Neutral
medium confidence
Mentioned
$CERS
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CERSNeutralLow
01

Why it matters

The 8-K adds specific compensation mechanics for the Executive Chairman role through May 31, 2027, including a $500,000 annual base salary, 2026 target cash bonus of 80% of base, and no annual cash bonus entitlement for 2027, plus COBRA premium reimbursement if coverage eligibility changes.

02

Market read

This is a governance and compensation update via SEC 8-K, with limited direct implications for revenue, margins, or near-term guidance.

03

What to watch

The filing does not quantify total incremental cost versus prior terms, and it omits any performance metrics tied to the 2026 target bonus, limiting how much traders can model earnings impact.

Relevance 6/10Novelty 4/10Timing: post-market after SEC 8-K filing (filed July 10, 2026)

Background

Cerus previously disclosed that William “Obi” Greenman stepped down as President and CEO and became Executive Chairman effective July 1, 2026.

Company-level read

Ticker impact

$CERSNeutralMedium confidence
Context

Cerus disclosed an 8-K amendment to Executive Chairman William “Obi” Greenman’s employment terms, including $500,000 base salary and bonus eligibility changes.

Expected impact

Low likelihood of a sustained move; any reaction is likely limited to governance sentiment and short-term expectations around executive compensation.

Evidence & confidence

The filing is a primary SEC disclosure of compensation structure tied to a role change effective July 1, 2026, with no new operational or financial guidance included.

Market effects

Minimal sector read-through; this is company-specific governance and compensation disclosure.

No clear regional spillover beyond US-listed small/mid-cap sentiment.

No direct global market relevance indicated.

Counterpoint

Investors may interpret the shift to Executive Chairman and the reduced 2027 bonus eligibility as a signal of leadership transition risk or cost-control, which could matter more than the filing suggests.

Key entities

  • Cerus Corporation

    Nasdaq-listed company filing the 8-K regarding executive departure/appointment and compensatory arrangements.

  • William “Obi” Greenman

    Former President and CEO, now Executive Chairman; amendment sets salary, bonus eligibility, and COBRA reimbursement terms.

Related articles

$CERSMed

CERUS CORP (CERS): Results of Operations and Financial Condition

CERUS CORP (CERS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cers-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Cerus Corporation Announces Second Quarter 2026 Financial Results Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y Raising Lower End of 2026 Product Revenue Gu

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.